InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,223.70
(
0.21%
)
Post# of 24568
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

noviceinvestor08

Send PM Follow Ignore
Followers 0
Posts 13
Boards Moderated 0
Alias Born 03/21/2010

noviceinvestor08

Re: None

Wednesday, 02/23/2011 9:33:35 AM

Wednesday, February 23, 2011 9:33:35 AM

Post# of 24568
Noticed CXM on the March FDA plays list with a 3/31 510k decision pending.

I was under the impression that March 31, was the date Cardium stated they would refile their revised 510k application for Excellagen by.

Can anyone shed some light? As a CXM holder I would love to be incorrect on this.

TIA

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up